Hills Bank & Trust’s GSK GSK Stock Holding History

Hills Bank & Trust’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.11M	Sell	20,139 -8,561	-30%	-$464K	0.05%	153
2025 Q4	$1.41M	Sell	28,700 -3,055	-10%	-$142K	0.08%	124
2025 Q3	$1.37M	Buy	31,755 +1,435	+5%	+$56.1K	0.08%	131
2025 Q2	$1.16M	Buy	30,320 +2,402	+9%	+$91.8K	0.07%	138
2025 Q1	$1.08M	Buy	27,918 +1,234	+5%	+$45.2K	0.08%	134
2024 Q4	$902K	Buy	26,684 +1,386	+5%	+$49.9K	0.07%	146
2024 Q3	$1.03M	Sell	25,298 -1,131	-4%	-$46.3K	0.08%	140
2024 Q2	$1.02M	Buy	26,429 +2,954	+13%	+$124K	0.08%	135
2024 Q1	$1.01M	Buy	23,475 +2,191	+10%	+$90.4K	0.09%	134
2023 Q4	$789K	Buy	21,284 +1,429	+7%	+$51.3K	0.08%	138
2023 Q3	$720K	Buy	19,855 +2,092	+12%	+$74.3K	0.08%	131
2023 Q2	$633K	Buy	17,763 +2,709	+18%	+$97.2K	0.08%	128
2023 Q1	$536K	Buy	15,054 +7,249	+93%	+$254K	0.07%	137
2022 Q4	$274K	Buy	+7,805	New	+$260K	0.04%	178

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hills Bank & Trust's GSK Position: Q1 2026 in Review

Hills Bank & Trust reduced its GSK (GSK) stake by 30% in Q1 2026, selling an estimated $464K and leaving 20,139 shares worth $1.11M. The position accounts for 0.05% of the portfolio, ranked #153.

Hills Bank & Trust first reported a position in GSK in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.41M in Q4 2025. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Hills Bank & Trust held 20,139 shares of GSK worth $1.11M as of Q1 2026.
Hills Bank & Trust sold 8,561 GSK shares in Q1 2026, an estimated $464K.
GSK made up 0.05% of Hills Bank & Trust's portfolio in Q1 2026, its #153 holding.
Hills Bank & Trust first reported a position in GSK in Q4 2022 and has held it in 14 quarters since.
Hills Bank & Trust's GSK position peaked at $1.41M in Q4 2025.
1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.